Key result
Prophylactic ephedrine infusion resulted in lower systolic blood pressure and more rescue vasopressor doses compared to norepinephrine during cesarean delivery under spinal anesthesia.
Why the study?
Ephedrine is typically the first-line treatment for maternal hypotension during cesarean section, but norepinephrine is gaining popularity in obstetric anesthesia.
Does prophylactic ephedrine versus norepinephrine infusion improve maternal hemodynamics and neonatal outcomes in patients undergoing cesarean delivery under spinal anesthesia?
RCT (n=100)
double-blind
randomized
Does prophylactic ephedrine versus norepinephrine infusion improve maternal hemodynamics and neonatal outcomes in patients undergoing cesarean delivery under spinal anesthesia?
Prophylactic norepinephrine infusion provides superior maternal hemodynamic stability and reduces the need for rescue vasopressors compared to ephedrine during cesarean delivery under spinal anesthesia.
Answers are grounded in this paper and cite their sources.
Norepinephrine infusion provides superior hemodynamic stability versus ephedrine in spinal cesarean delivery; supports preferential use and further outcome trials.
Background Ephedrine (EPH) is generally the first-line treatment for maternal hypotension during cesarean sections, although norepinephrine (NE) is gaining popularity in obstetric anesthesia. This study aims to compare the impact of prophylactic EPH versus NE infusion on maternal hemodynamics and newborn outcomes after spinal anesthesia (SA) in cesarean delivery. Aim To compare prophylactic EPH versus NE infusion on maternal hemodynamics and neonatal outcome following SA in cesarean delivery. Patients and methods This prospective randomized, double-blind trial included 100 female patients over the age of 21, all prepared for elective cesarean section under SA. Participants were placed into two groups, with infusion initiated just before the intrathecal injection and continued until delivery: group A received a 4 mg/min dose of EPH, and group B received NE at a dose of 4 mg/min. Results Group A had significantly higher heart rates and lower systolic blood pressure at multiple times (4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, and 60 min) compared to group B ( P <0.05). Group A received a significantly greater number of rescue doses than group B ( P =0.04). The APGAR scores and adverse effects at 1 and 5 min were not significantly different between the two groups. Conclusions In preventing hypotension during SA, NE infusion demonstrated superior hemodynamic stability resulting in fewer rescue doses of vasopressors without difference in neonatal outcomes and side effects regarding vomiting, nausea, and hypotension.
No takes yet. Share an insight, caveat, or question.
Fouda et al. (2026) conducted an RCT in elective cesarean section under spinal anesthesia (n=100). Ephedrine vs. Norepinephrine (4 mg/min) was evaluated on Maternal hemodynamics and neonatal outcome (p=<0.05). Prophylactic ephedrine infusion resulted in lower systolic blood pressure and more rescue vasopressor doses compared to norepinephrine during cesarean delivery under spinal anesthesia.
Synapse has enriched 10 related papers. Consider them for comparative context: